Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd. Stock Analysis 002864.SZ

Shaanxi Panlong Pharmaceutical Group Ltd. By Share Ltd. engages in the GAP cultivation of medicinal materials, pharmaceutical production, research & development, sale and pharmaceutical logistics. The company is headquartered in Xi'An, Shaanxi and currently employs 926 full-time employees. The company went IPO on 2017-11-16. The firm's main products include Panlong Qipian, Panlong Qi Yao Jiu, Jin Yin Li Dan Capsules, Kebireti Tablets, Compound Gossypol Acetate Tablets, Gossypol Acetate API, functional health food Gujiaoguizhen Tablets, health care product Panlong Qi Tie and others. The firm's products cover categories such as rheumatism and bone injuries, cardiovascular and cerebrovascular diseases, digestion, tonification, clearing heat and detoxification, pediatrics, gynecology, and liver and gallbladder diseases. The firm mainly operates its businesses in the domestic market.